Mirae Asset Global Investments Co. Ltd. Increases Stock Position in Ventas, Inc. $VTR

Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Ventas, Inc. (NYSE:VTR) by 10.8% in the third quarter, HoldingsChannel reports. The firm owned 86,099 shares of the real estate investment trust’s stock after acquiring an additional 8,358 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Ventas were worth $6,026,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of the stock. True Wealth Design LLC grew its holdings in Ventas by 1,557.7% during the 3rd quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock valued at $30,000 after buying an additional 405 shares during the last quarter. ORG Partners LLC lifted its position in shares of Ventas by 76.1% in the third quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock valued at $32,000 after acquiring an additional 197 shares in the last quarter. Wilmington Savings Fund Society FSB boosted its stake in shares of Ventas by 65.5% during the third quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock valued at $32,000 after acquiring an additional 180 shares during the last quarter. Ameritas Advisory Services LLC purchased a new stake in Ventas during the 2nd quarter worth about $33,000. Finally, Golden State Wealth Management LLC raised its stake in Ventas by 52.7% in the 2nd quarter. Golden State Wealth Management LLC now owns 536 shares of the real estate investment trust’s stock valued at $34,000 after purchasing an additional 185 shares during the last quarter. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have issued reports on VTR. Weiss Ratings raised shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. Jefferies Financial Group reissued a “buy” rating and set a $93.00 price objective on shares of Ventas in a research note on Monday, December 15th. Scotiabank lifted their target price on shares of Ventas from $74.00 to $80.00 and gave the stock a “sector perform” rating in a research note on Thursday, November 13th. Citigroup boosted their price target on Ventas from $80.00 to $88.00 and gave the company a “buy” rating in a report on Tuesday, November 11th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $93.00 price objective on shares of Ventas in a report on Monday, January 5th. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Ventas presently has an average rating of “Moderate Buy” and an average target price of $81.63.

Ventas Price Performance

Shares of Ventas stock opened at $77.65 on Friday. The business’s fifty day moving average price is $78.20 and its 200 day moving average price is $72.78. Ventas, Inc. has a twelve month low of $58.72 and a twelve month high of $81.89. The company has a current ratio of 0.32, a quick ratio of 0.32 and a debt-to-equity ratio of 1.01. The stock has a market capitalization of $36.48 billion, a P/E ratio of 149.33, a PEG ratio of 1.90 and a beta of 0.78.

Ventas (NYSE:VTR) last released its quarterly earnings data on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.01. Ventas had a return on equity of 2.05% and a net margin of 4.28%.The business had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.44 billion. During the same period in the previous year, the company posted $0.80 EPS. The company’s revenue was up 20.5% compared to the same quarter last year. As a group, research analysts anticipate that Ventas, Inc. will post 3.4 earnings per share for the current year.

Ventas Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Wednesday, December 31st were given a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Wednesday, December 31st. Ventas’s payout ratio is 369.23%.

Insiders Place Their Bets

In related news, CFO Robert F. Probst sold 29,930 shares of the stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $77.25, for a total value of $2,312,092.50. Following the completion of the sale, the chief financial officer directly owned 138,434 shares in the company, valued at approximately $10,694,026.50. This represents a 17.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Debra A. Cafaro sold 10,322 shares of the firm’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $77.26, for a total value of $797,477.72. Following the completion of the transaction, the chief executive officer directly owned 1,145,695 shares in the company, valued at $88,516,395.70. This trade represents a 0.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 176,747 shares of company stock worth $13,579,533 over the last ninety days. 0.80% of the stock is owned by company insiders.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.